help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernández, L.
Right arrow Articles by Gustafsson, J.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernández, L.
Right arrow Articles by Gustafsson, J.-A.
Endocrinology Vol. 139, No. 4 1815-1824
Copyright © 1998 by The Endocrine Society

ARTICLES

Desensitization of the Growth Hormone-Induced Janus Kinase 2 (Jak 2)/Signal Transducer and Activator of Transcription 5 (Stat5)-Signaling Pathway Requires Protein Synthesis and Phospholipase C1

Leandro Fernández, Amilcar Flores-Morales, Olivier Lahuna, Daniel Sliva, Gunnar Norstedt, Lars-Arne Haldosén2, Agneta Mode and Jan-Åke Gustafsson

Department of Medical Nutrition, Karolinska Institute, Novum, S-141 86 Huddinge, Sweden

Address all correspondence and requests for reprints to: Agneta Mode, Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, Novum, S-141 86 Huddinge, Sweden. E-mail: Agneta.Mode{at}mednut.ki.se

Signal transducers and activators of transcription (Stat) proteins are latent cytoplasmic transcription factors that are tyrosine phosphorylated by Janus kinases (Jak) in response to GH and other cytokines. GH activates Stat5 by a mechanism that involves tyrosine phosphorylation and nuclear translocation. However, the mechanisms that turn off the GH-activated Jak2/Stat5 pathway are unknown. Continuous exposure to GH of BRL-4 cells, a rat hepatoma cell line stably transfected with rat GH receptor, induces a rapid but transient activation of Jak2 and Stat5. GH-induced Stat5 DNA-binding activity was detected after 2 min and reached a maximum at 10 min. Continued exposure to GH resulted in a desensitization characterized by 1) a rapid decrease in Stat5 DNA-binding activity. The rate of decrease of activity was rapid up to 1 h of GH treatment, and the remaining activity declined slowly thereafter. The activity of Stat5 present after 5 h is still higher than the control levels and almost 10–20% with respect to maximal activity at 10 min; and 2) the inability of further GH treatment to reinduce activation of Stat5. In contrast, with transient exposures of BRL-4 cells to GH, Stat5 DNA-binding activity could repeatedly be induced. GH-induced Jak2 and Stat5 activities were independent of ongoing protein synthesis. However, Jak2 tyrosine phosphorylation and Stat5 DNA-binding activity were prolonged for at least 4 h in the presence of cycloheximide, which suggests that the maintenance of desensitization requires ongoing protein synthesis. Furthermore, inhibition of protein synthesis potentiated GH-induced transcriptional activity in BRL-4 cells transiently transfected with SPIGLE1CAT, a reporter plasmid activated by Stat5. GH-induced Jak2 and Stat5 activation were not affected by D609 or mepacrine, both inhibitors of phospholipase C. However, in the presence of D609 and mepacrine, GH maintained prolonged Jak2 and Stat5 activation. Transactivation of SPIGLE1 by GH was potentiated by mepacrine and D609 but not by the phospholipase A2 inhibitor AACOCF3. Thus, a regulatory circuit of GH-induced transcription through the Jak2/Stat5-signaling pathway includes a prompt GH-induced activation of Jak2/Stat5 followed by a negative regulatory response; ongoing protein synthesis and intracellular signaling pathways, where phospholipase C activity is involved, play a critical role to desensitize the GH-activated Jak2/Stat5-signaling pathway.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
Y. Wei, S. Puzhko, M. Wabitsch, and C. G. Goodyer
Transcriptional Regulation of the Human Growth Hormone Receptor (hGHR) Gene V2 Promoter by Transcriptional Activators and Repressor
Mol. Endocrinol., March 1, 2009; 23(3): 373 - 387.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. H. Elsasser, C.-J. Li, T. J. Caperna, S. Kahl, and W. F. Schmidt
Growth Hormone (GH)-Associated Nitration of Janus Kinase-2 at the 1007Y-1008Y Epitope Impedes Phosphorylation at This Site: Mechanism for and Impact of a GH, AKT, and Nitric Oxide Synthase Axis on GH Signal Transduction
Endocrinology, August 1, 2007; 148(8): 3792 - 3802.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
O. M. Vidal, R. Merino, E. Rico-Bautista, L. Fernandez-Perez, D. J. Chia, J. Woelfle, M. Ono, B. Lenhard, G. Norstedt, P. Rotwein, et al.
In Vivo Transcript Profiling and Phylogenetic Analysis Identifies Suppressor of Cytokine Signaling 2 as a Direct Signal Transducer and Activator of Transcription 5b Target in Liver
Mol. Endocrinol., January 1, 2007; 21(1): 293 - 311.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. J. Waxman and C. O'Connor
Growth Hormone Regulation of Sex-Dependent Liver Gene Expression
Mol. Endocrinol., November 1, 2006; 20(11): 2613 - 2629.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Flores-Morales, C. J. Greenhalgh, G. Norstedt, and E. Rico-Bautista
Negative Regulation of Growth Hormone Receptor Signaling
Mol. Endocrinol., February 1, 2006; 20(2): 241 - 253.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho
Estrogen Regulation of Growth Hormone Action
Endocr. Rev., October 1, 2004; 25(5): 693 - 721.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn
Suppression of Growth Hormone (GH) Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 5 Signaling Pathway in Transgenic Mice Overexpressing Bovine GH
Endocrinology, June 1, 2004; 145(6): 2824 - 2832.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Du, G. P. Frick, L.-R. Tai, A. Yoshimura, and H. M. Goodman
Interaction of the Growth Hormone Receptor with Cytokine-Induced Src Homology Domain 2 Protein in Rat Adipocytes
Endocrinology, March 1, 2003; 144(3): 868 - 876.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Graichen, J. Sandstedt, E. L. K. Goh, O. G. P. Isaksson, J. Tornell, and P. E. Lobie
The Growth Hormone-binding Protein Is a Location-dependent Cytokine Receptor Transcriptional Enhancer
J. Biol. Chem., February 14, 2003; 278(8): 6346 - 6354.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Helander, J.-A. Gustafsson, and A. Mode
Possible Involvement of Truncated Signal Transducer and Activator of Transcription-5 in the GH Pattern-Dependent Regulation of CYP2C12 Gene Expression in Rat Liver
Mol. Endocrinol., July 1, 2002; 16(7): 1598 - 1611.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Gonzalez, J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn
Cytokine-Inducible SH2 Protein Up-Regulation Is Associated with Desensitization of GH Signaling in GHRH-Transgenic Mice
Endocrinology, February 1, 2002; 143(2): 386 - 394.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. S. Tannenbaum, H. K. Choi, W. Gurd, and D. J. Waxman
Temporal Relationship Between the Sexually Dimorphic Spontaneous GH Secretory Profiles and Hepatic STAT5 Activity
Endocrinology, November 1, 2001; 142(11): 4599 - 4606.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Flores-Morales, L. Fernandez, E. Rico-Bautista, A. Umana, C. Negrin, J.-G. Zhang, and G. Norstedt
Endoplasmic Reticulum Stress Prolongs GH-Induced Janus Kinase (JAK2)/Signal Transducer and Activator of Transcription (STAT5) Signaling Pathway
Mol. Endocrinol., September 1, 2001; 15(9): 1471 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
O. Lahuna, M. Rastegar, D. Maiter, J.-P. Thissen, F. P. Lemaigre, and G. G. Rousseau
Involvement of STAT5 (Signal Transducer and Activator of Transcription 5) and HNF-4 (Hepatocyte Nuclear Factor 4) in the Transcriptional Control of the hnf6 Gene by Growth Hormone
Mol. Endocrinol., February 1, 2000; 14(2): 285 - 294.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
Y. Sasaki, Y. Takahashi, K. Nakayama, and T. Kamataki
Cooperative Regulation of CYP2C12 Gene Expression by STAT5 and Liver-specific Factors in Female Rats
J. Biol. Chem., December 24, 1999; 274(52): 37117 - 37124.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. A. Ram and D. J. Waxman
SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms
J. Biol. Chem., December 10, 1999; 274(50): 35553 - 35561.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Tollet-Egnell, A. Flores-Morales, A. Stavréus-Evers, L. Sahlin, and G. Norstedt
Growth Hormone Regulation of SOCS-2, SOCS-3, and CIS Messenger Ribonucleic Acid Expression in the Rat
Endocrinology, August 1, 1999; 140(8): 3693 - 3704.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
E. L. K. Goh, T. Zhu, S. Yakar, D. LeRoith, and P. E. Lobie
CrkII Participation in the Cellular Effects of Growth Hormone and Insulin-like Growth Factor-1. PHOSPHATIDYLINOSITOL-3 KINASE DEPENDENT AND INDEPENDENT EFFECTS
J. Biol. Chem., June 2, 2000; 275(23): 17683 - 17692.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. A. Ram and D. J. Waxman
Role of the Cytokine-inducible SH2 Protein CIS in Desensitization of STAT5b Signaling by Continuous Growth Hormone
J. Biol. Chem., December 8, 2000; 275(50): 39487 - 39496.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society